demonstrated that the interaction of TN-C with annexin II, which is known to be able to bind to alternative splicing domain of TN-C, is capable of driving EMT and following acquisition of anoikis resistance in pancreatic cancer (61). This evidence concerns the gene TNC and pancreatic neoplasm.